Product NDC: | 51645-717 |
Proprietary Name: | ASPIRIN |
Non Proprietary Name: | ASPIRIN |
Active Ingredient(s): | 81 mg/1 & nbsp; ASPIRIN |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51645-717 |
Labeler Name: | Gemini Pharmaceuticals, Inc. dba Plus Pharmaceuticals |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part343 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20130110 |
Package NDC: | 51645-717-08 |
Package Description: | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51645-717-08) |
NDC Code | 51645-717-08 |
Proprietary Name | ASPIRIN |
Package Description | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51645-717-08) |
Product NDC | 51645-717 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | ASPIRIN |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20130110 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Gemini Pharmaceuticals, Inc. dba Plus Pharmaceuticals |
Substance Name | ASPIRIN |
Strength Number | 81 |
Strength Unit | mg/1 |
Pharmaceutical Classes |